HDAC9 and pulmonary arterial hypertension: Interestingly, the decrease in miR-124 was restored by treatment with HDAC inhibitors, but not by 5-aza-deoxycytidine in hypertensive fibroblasts.36 These studies suggest therapeutic potential for HDACs inhibitors in the treatment of PAH.